The Federal Government Wants a Kill Switch on Research Funding
The United States built its scientific reputation on a straightforward principle: the people best qualified to judge research proposals are the scientists who actually understand them. Peer reviewers scored applications on quality and feasibility, and subject-matter experts inside funding agencies used those scores to decide where money went. That system, running largely unchanged for decades, is now the explicit target of a formal federal rulemaking effort from the Office of Management and Budget.
The OMB’s proposed rules would hand final funding decisions to political appointees – and those appointees are specifically directed not to “routinely defer” to peer reviewers.
This isn’t the first attempt. Last August, the Trump administration issued an executive order aimed at restructuring how federal grants are handled. That order ran into a wall of court losses, because executive orders still have to satisfy legal requirements, and judges found insufficient justification to let the changes stand. Rather than issue another vulnerable order, the OMB folded the original priorities into the formal federal rulemaking process – a procedural move that makes the proposed changes significantly harder to strike down in court.
What the Rules Actually Say
The proposed framework goes well beyond reshuffling who sits at the head of the table. Any federal agency would gain the authority to cancel any grant at any time, with justification as thin as asserting that a project isn’t in the “national interest.” That phrase appears nowhere near a legal definition in the proposal, which means the cancellation power is effectively discretionary and nearly unchecked. A researcher mid-project, with equipment purchased, staff hired, and data half-collected, could lose funding on a determination that carries no scientific standard whatsoever.
The rules also ban grants on a range of topics that have become targets in ongoing culture war disputes, restrict international research collaborations, and block spending on activities like publishing papers and attending academic conferences. That last restriction deserves particular attention: publishing and conference attendance are not perks of the job. They are the mechanism through which findings enter the shared scientific record, get scrutinized by other researchers, and eventually become the kind of verified knowledge that informs medicine, engineering, climate modeling, and defense technology. Blocking that spending doesn’t just inconvenience researchers – it severs the pipeline between federally funded work and practical application.
Taken together, the proposed rules create a system where scientific merit is a secondary input at best, and political alignment is the primary filter. Peer review remains technically present in the process, but stripping its authority while instructing decision-makers to ignore it produces something that looks like oversight without functioning as any.
Why the Rulemaking Route Changes the Stakes
The shift to formal federal rulemaking isn’t just procedural housekeeping. When the administration lost court cases over the August executive order, those losses stemmed from a lack of strong justification and failure to follow legal requirements. The rulemaking process forces public comment periods and creates a documented record – but it also produces rules that carry greater legal weight and are substantially harder to vacate than executive orders issued without that process.
That means the scientific community, universities, and advocacy organizations opposing these changes face a different legal landscape than they did when challenging the original order. The window to shape the outcome through public comment is finite, and once rules are finalized through this process, reversing them requires either litigation on new grounds or a future administration willing to run the same rulemaking procedure in reverse.
The infrastructure that powers research computing has been expanding in the private sector, but federal grant funding remains the primary engine behind basic science – the kind of early-stage, uncertain work that private investors won’t touch because the payoff horizon is too long and too speculative. Pharmaceutical breakthroughs, materials science advances, and foundational AI research have all traced back, at some point, to federally funded basic research that had no obvious commercial application at the time it was conducted.
A System Designed to Produce Different Outcomes
What the OMB has proposed is not a reform of how science gets funded – it is a replacement of the criteria by which funding decisions get made. The peer review system was designed specifically to keep those decisions anchored to scientific merit rather than political preference, because scientific merit produces reliable results and political preference historically does not. The proposed rules don’t argue that peer review has failed or produced bad science. They simply subordinate it to a different priority structure, one in which political appointees hold discretionary cancellation authority over work they were not trained to evaluate.
If finalized, these rules would apply across federal agencies – meaning the National Institutes of Health, the National Science Foundation, the Department of Energy’s research programs, and every other body that funds scientific work would operate under the same framework. The scale of potential disruption isn’t limited to a handful of contested grants. It touches the entire architecture of how the US produces and disseminates scientific knowledge.
The last time a major scientific power systematically subordinated research priorities to political ideology, the results took generations to undo.
Somewhere right now, a graduate student is three years into a federally funded project, writing up results to submit to a journal – work that, under these rules, could be defunded before the paper clears peer review, for reasons that no scientific body would be required to validate.
